Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting

NCT01079364 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

52

Enrollment

INDUSTRY

Sponsor class

Stopped Slow recruitment

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin glulisine
DRUG: Insulin glargine
DRUG: Premixed insulin (Insulin Aspart 30/70 )

Sponsor

Sanofi